COLESTIPOL HYDROCHLORIDE
NDC 0115-5213, COLESTIPOL HYDROCHLORIDE, suspension, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 0115-5213
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077277
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0115-5213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COLESTIPOL HYDROCHLORIDE5 g/1
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0115-5213-02 | 00115521302 | 100 SUSPENSION in 1 BOTTLE (0115-5213-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/839354bd-cbac-4d18-8c02-b1b93766af38
Use it
Look up 0115-5213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0115-5213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0115-5213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.